Hong Kong diabetes fatty liver disease study

This study follows people with type 2 diabetes and a common liver condition called MASLD to see how their heart health changes over time. It aims to find better ways to prevent heart disease in people with both conditions.

This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.

This study looks at how early biological aging might increase the chance of developing type 2 diabetes in people with a fatty liver (a condition called MASLD). It uses routine health check-up data to understand the link.

This study looks at how people with fatty liver and type 2 diabetes respond to glucagon, a hormone that helps control blood sugar. It may help researchers understand a condition called 'glucagon resistance' and find better treatments.

This study classifies fatty liver disease (MAFLD) by examining liver tissue samples. It aims to better understand how metabolic risk factors like high blood sugar, high blood pressure, or excess weight relate to the liver's condition.

This study looks at how fat tissue works differently in people with type 1 diabetes who have belly fat, and how that might lead to fat buildup in the liver. It compares these people to those without diabetes, matched by age, waist size, and menopausal status, to find new ways to prevent liver problems.